Abbvie Inc
NYSE: ABBV
$175.55
-$1.19 (-0.7%)
Closing Price on January 14, 2025
ABBV Stock Chart and Intraday Price
ABBV Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 316,039.17M USD |
| Shares Outstanding | 1,766,470,000 |
ABBV Articles
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
Published:
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
Some of the best stocks for income investors are the Dividend Kings. Here are five that are perfect for retired baby boomers now.
Published:
Donald Trump’s victory is positive for the stock market. The healthcare sector has underperformed and offers enormous upside. Healthcare stocks pay some of the most reliable dividends. Proper...
Published:
Companies with high dividend yields are relatively uncommon in this market. In fact, the average yield on the S&P 500 (albeit one which is heavily weighted toward tech stocks) is around 1.2%. So,...
Published:
24/7 Wall St. Insights: AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are now questioning the pharma’s pipeline, raising...
Published:
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.55, payable on Tuesday Oct. 15th. While investors will wait to hear about quarterly earnings on Oct....
Published:
The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we need it, to everyday pain remediation or allergy medications, big pharma...
Published:
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
Published:
The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence that propelled Nvidia (NASDAQ:NVDA) to the forefront of the industry. The...
Published:
A recession is looming. Despite the S&P 500 nearing its all-time high, the yield curve inverted and the Sahm Rule was activated. The Federal Reserve is also poised to initiate the first interest...
Published:
24/7 Wall St. Insights Stocks that consistently raise their dividends offer investors huge total return potential. Dividend stocks will become more popular as interest rates decline. Grab this free...
Published:
Dividend stocks can provide investors with passive long-term income. AbbVie offers stable and consistent distributions. Realty Income has increased its dividend for 25 consecutive years. Also: 2...
Published:
24/7 Insights Dividend Aristocrat shareholders could see some big upside in August. Looking at quality stocks that pay dependable quarterly dividends makes sense now. Also: 2 Dividend Legends to Hold...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.